Sands Capital Ventures as of March 31, 2025
Portfolio Holdings for Sands Capital Ventures
Sands Capital Ventures holds 20 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Klaviyo Com Ser A (KVYO) | 25.5 | $104M | 3.4M | 30.26 | |
| Nu Hldgs Ord Shs Cl A (NU) | 17.9 | $73M | 7.2M | 10.24 | |
| Doordash Cl A (DASH) | 17.0 | $70M | 381k | 182.77 | |
| Beta Bionics (BBNX) | 9.3 | $38M | 3.1M | 12.24 | |
| Inhibikase Therapeutics Com New (IKT) | 5.9 | $24M | 11M | 2.19 | |
| Coupang Cl A (CPNG) | 4.5 | $19M | 844k | 21.93 | |
| Monday SHS (MNDY) | 3.0 | $12M | 50k | 243.16 | |
| Datadog Cl A Com (DDOG) | 2.9 | $12M | 118k | 99.21 | |
| Samsara Com Cl A (IOT) | 2.4 | $9.7M | 253k | 38.33 | |
| Tarsus Pharmaceuticals (TARS) | 2.1 | $8.7M | 170k | 51.37 | |
| Toast Cl A (TOST) | 1.7 | $7.0M | 211k | 33.17 | |
| Crowdstrike Hldgs Cl A (CRWD) | 1.3 | $5.5M | 16k | 352.58 | |
| Acrivon Therapeutics Common Stock (ACRV) | 1.1 | $4.3M | 2.1M | 2.03 | |
| 10x Genomics Cl A Com (TXG) | 1.0 | $4.2M | 482k | 8.73 | |
| Uipath Cl A (PATH) | 1.0 | $4.1M | 396k | 10.30 | |
| Snowflake Cl A (SNOW) | 1.0 | $3.9M | 27k | 146.16 | |
| Acumen Pharmaceuticals (ABOS) | 0.9 | $3.8M | 3.4M | 1.10 | |
| Bioage Labs (BIOA) | 0.7 | $3.0M | 786k | 3.76 | |
| Candel Therapeutics (CADL) | 0.6 | $2.3M | 406k | 5.65 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.2 | $1.0M | 725k | 1.39 |
